Advanced analytics has shaped the healthcare industry in significant ways. It has shown to impact the way healthcare is delivered and received by streamlining workflows, improving the patient experience, and lowering overall costs. Now, not only is the use of advanced analytics widespread—47% of providers are currently using the tool—but 93% of healthcare executives also consider it important to the future of their business.

The healthcare space has much to gain from adopting advanced analytics, a fact that’s becoming more and more apparent during the coronavirus pandemic. In an industry where evidence-based decision-making and proactive intervention can save lives, it has become critical to analyze massive sets of data to streamline clinical and administrative workflows, enhance diagnostic accuracy, improve patient outcomes, and even lower overall expenditures.

In hospitals around the world, ICU hospital beds and ventilators are reserved for patients—regardless of age—who are in critical condition and require mechanical support to keep their bodies functioning and to fight the onset of sepsis. This condition is a complication caused by the human body’s response to infection, and it can lead to organ failure and death, accounting for 1 in 5 deaths globally.

Analyze, identify, and treat patients at risk of sepsis-associated mortality and morbidity as a result of respiratory failure. Every few years, we are faced with strains of antibiotic resistant bacteria—SARs, Ebola, MERS, H1N1, and most recently COVID-19. Are we prepared to handle this kind of pandemic as COVID-19 will not be the last one to put a strain on the healthcare system.

When a market grows as quickly as implantable medical devices, set to top a staggering $153.8 billion by 2026, the potential risk to patients can rise as well. As implantable medical devices proliferate, so do the number of costly, life-threatening, and reputation-tarnishing recalls. A single large recall can account for millions of device units.

One of the first recorded medical devices was the stethoscope in 1816. Fast forward more than a century to 2019, where the world witnessed the creation of an award-winning multi-sensor, implantable cardiac device able to predict potential heart failure weeks in advance. The data and analytics streamed and analyzed from new connected devices are transforming healthcare as we know it. However, a real challenge in this environment is the sheer volume and scope of data that must be managed and protected.

At Hitachi Vantara, our mission is to help customers extract all the value of their data through our DataOps methodology, which helps them achieve tangible outcomes that positively drive business and society forward. One field where we’re making advances – which also strikes a personal chord with me, given my background as a biomedical engineer – is in the field of cardiovascular medicine. Specifically, I’m referring to our work with the American Heart Association (AHA).

We’ve got a lot of customers in the healthcare space. It’s a really interesting space to be in from an analytics perspective because our customers are based across the world and have a wide variety of use cases - from financial administration all the way through to hospital performance and risk metrics.